The HIV-associated tuberculosis epidemic—when will we act?

[1]  P. Phanuphak,et al.  An algorithm for tuberculosis screening and diagnosis in people with HIV. , 2010, The New England journal of medicine.

[2]  W. El-Sadr,et al.  Timing of initiation of antiretroviral drugs during tuberculosis therapy. , 2010, The New England journal of medicine.

[3]  S. Lawn,et al.  Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis , 2010, The Lancet. Infectious diseases.

[4]  I. Adetifa,et al.  Treatment of latent tuberculosis infection in HIV infected persons. , 2010, The Cochrane database of systematic reviews.

[5]  S. Adjei,et al.  Integration of control of neglected tropical diseases into health-care systems: challenges and opportunities , 2010, The Lancet.

[6]  A. Breckenridge,et al.  Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial , 2010, The Lancet.

[7]  S. Jaffar,et al.  Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial , 2009, The Lancet.

[8]  Michael J Silverberg,et al.  Effect of early versus deferred antiretroviral therapy for HIV on survival. , 2009, The New England journal of medicine.

[9]  S. Lawn,et al.  Antiretroviral Therapy for Control of the HIV-associated Tuberculosis Epidemic in Resource-Limited Settings , 2009, Clinics in chest medicine.

[10]  W. El-Sadr,et al.  Health systems exist for real people. Introduction. , 2009, Journal of acquired immune deficiency syndromes.

[11]  A. Harries,et al.  How health systems in sub-Saharan Africa can benefit from tuberculosis and other infectious disease programmes. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[12]  R. Hayes,et al.  Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for control. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[13]  S. Lawn,et al.  HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response , 2009, The Lancet.

[14]  S. Lawn,et al.  Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease , 2009, AIDS.

[15]  L. Myer,et al.  Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa , 2009, AIDS.

[16]  A. Van Deun,et al.  Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  B. Eley,et al.  Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants. , 2009, Bulletin of the World Health Organization.

[18]  S. Lawn,et al.  Epidemiology of HIV-associated tuberculosis , 2009, Current opinion in HIV and AIDS.

[19]  Tim Evans,et al.  An assessment of interactions between global health initiatives and country health systems , 2009, The Lancet.

[20]  J. Kaufman,et al.  Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  A. Harries,et al.  Patient retention and attrition on antiretroviral treatment at district level in rural Malawi. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[22]  A D Harries,et al.  Task shifting in HIV/AIDS: opportunities, challenges and proposed actions for sub-Saharan Africa. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[23]  C. Sismanidis,et al.  Prevalence of Tuberculosis, HIV and Respiratory Symptoms in Two Zambian Communities: Implications for Tuberculosis Control in the Era of HIV , 2009, PloS one.

[24]  A. Zolopa,et al.  Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial , 2009, PloS one.

[25]  Stephen R Cole,et al.  Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies , 2009, The Lancet.

[26]  L. Lambert,et al.  Intensified Tuberculosis Case Finding Among HIV-Infected Persons From a Voluntary Counseling and Testing Center in Addis Ababa, Ethiopia , 2009, Journal of acquired immune deficiency syndromes.

[27]  R. Chaisson,et al.  Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort , 2009, AIDS.

[28]  A. R. Escombe,et al.  Upper-Room Ultraviolet Light and Negative Air Ionization to Prevent Tuberculosis Transmission , 2009, PLoS medicine.

[29]  Payam Tabarsi,et al.  Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV , 2009, Journal of the International AIDS Society.

[30]  C. Barros,et al.  Effect of Simultaneous Use of Highly Active Antiretroviral Therapy on Survival of HIV Patients With Tuberculosis , 2009, Journal of acquired immune deficiency syndromes.

[31]  Christopher Dye,et al.  Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model , 2009, The Lancet.

[32]  Ying-Ru Lo,et al.  Can antiretroviral therapy eliminate HIV transmission? , 2009, The Lancet.

[33]  U. Lalloo,et al.  Successful Integration of Tuberculosis and HIV Treatment in Rural South Africa: The Sizonq'oba Study , 2009, Journal of acquired immune deficiency syndromes.

[34]  D. Menzies,et al.  Preventive chemotherapy. Where has it got us? Where to go next? , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[35]  Richard D Moore,et al.  Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil , 2008, AIDS.

[36]  James A McIntyre,et al.  Early antiretroviral therapy and mortality among HIV-infected infants. , 2008, The New England journal of medicine.

[37]  L. Myer,et al.  Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa , 2008, AIDS.

[38]  A. R. Escombe,et al.  The Infectiousness of Tuberculosis Patients Coinfected with HIV , 2008, PLoS medicine.

[39]  Madhukar Pai,et al.  Systematic Review: T-Cellbased Assays for the Diagnosis of Latent Tuberculosis Infection: An Update , 2008, Annals of Internal Medicine.

[40]  Alimuddin Zumla,et al.  Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial , 2008, BMJ : British Medical Journal.

[41]  S. Lawn,et al.  Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy. , 2008, American journal of respiratory and critical care medicine.

[42]  M. Perkins,et al.  Confronting the scientific obstacles to global control of tuberculosis. , 2008, The Journal of clinical investigation.

[43]  Anthony D Harries,et al.  Assessing the quality of data aggregated by antiretroviral treatment clinics in Malawi. , 2008, Bulletin of the World Health Organization.

[44]  Brook K. Baker,et al.  The 'diagonal' approach to Global Fund financing: a cure for the broader malaise of health systems? , 2008, Globalization and health.

[45]  K. D. de Cock,et al.  Provider-initiated HIV testing and counselling for TB patients and suspects in Nairobi, Kenya. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[46]  M. Kimerling,et al.  Pulmonary tuberculosis among patients visiting a voluntary confidential counseling and testing center, Cambodia. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[47]  R. Zachariah,et al.  Task shifting for antiretroviral treatment delivery in sub-Saharan Africa: not a panacea , 2008, The Lancet.

[48]  J. Tappero,et al.  Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study , 2008, The Lancet.

[49]  Mark Dybul,et al.  Rapid expansion of the health workforce in response to the HIV epidemic. , 2007, The New England journal of medicine.

[50]  E. Schouten,et al.  A national survey of the impact of rapid scale-up of antiretroviral therapy on health-care workers in Malawi: effects on human resources and survival. , 2007, Bulletin of the World Health Organization.

[51]  K. Laserson,et al.  Impact of Antiretroviral Therapy on the Incidence of Tuberculosis: The Brazilian Experience, 1995–2001 , 2007, PloS one.

[52]  Anthony Harries,et al.  Lower Early Mortality Rates Among Patients Receiving Antiretroviral Treatment at Clinics Offering Cotrimoxazole Prophylaxis in Malawi , 2007, Journal of acquired immune deficiency syndromes.

[53]  Ezio Távora dos Santos Filho,et al.  Strategies for tuberculosis control in Brazil: networking and civil society participation , 2007 .

[54]  E. Nardell,et al.  Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment. , 2007, The Journal of infectious diseases.

[55]  R. Chaisson,et al.  Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities. , 2007, The Journal of infectious diseases.

[56]  Richard D Moore,et al.  The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil , 2007, AIDS.

[57]  S. Swaminathan,et al.  Childhood tuberculosis - global epidemiology and the impact of HIV. , 2007, Paediatric respiratory reviews.

[58]  B. D. de Jong,et al.  Treatment outcomes of patients with HIV and tuberculosis. , 2007, American journal of respiratory and critical care medicine.

[59]  G. Rutherford,et al.  Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda , 2007, AIDS.

[60]  Y. Cheung,et al.  Nursing and community rates of Mycobacterium tuberculosis infection among students in Harare, Zimbabwe. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[61]  A. R. Escombe,et al.  Natural Ventilation for the Prevention of Airborne Contagion , 2007, PLoS medicine.

[62]  R. Hayes,et al.  Epidemiology of Tuberculosis in a High HIV Prevalence Population Provided with Enhanced Diagnosis of Symptomatic Disease , 2007, PLoS medicine.

[63]  Neel R Gandhi,et al.  Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa , 2006, The Lancet.

[64]  H. Zar,et al.  Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial , 2006, BMJ : British Medical Journal.

[65]  S. Lawn,et al.  Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study , 2006, The Lancet.

[66]  Milton C Weinstein,et al.  Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire. , 2006, The New England journal of medicine.

[67]  K. D. de Cock,et al.  HIV prevention for a threatened continent: implementing positive prevention in Africa. , 2006, JAMA.

[68]  L. Myer,et al.  Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control , 2006, AIDS.

[69]  S. van der Meij,et al.  The fight against stigma: An overview of stigma-reduction strategies and interventions , 2006, Psychology, health & medicine.

[70]  E. Bateman,et al.  An evaluation of symptom and chest radiographic screening in tuberculosis prevalence surveys. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[71]  R. Miller,et al.  Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy. , 2006, The Journal of infectious diseases.

[72]  G J Churchyard,et al.  Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[73]  J. P. Ekwaru,et al.  Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study , 2006, The Lancet.

[74]  C. Dye,et al.  Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness , 2006, The Lancet.

[75]  R. Zachariah,et al.  Cotrimoxazole prophylaxis for HIV-positive TB patients in developing countries , 2006, Tropical doctor.

[76]  B. Marston,et al.  Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment , 2006, The Lancet.

[77]  M. Raviglione.  The Global Plan to Stop TB, 2006-2015. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[78]  A. Harries,et al.  How can the community contribute in the fight against HIV/AIDS and tuberculosis? An example from a rural district in Malawi. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[79]  S. Lawn,et al.  Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort , 2005, AIDS.

[80]  R. Chaisson,et al.  Active case finding of tuberculosis: historical perspective and future prospects. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[81]  C. Dye,et al.  Tuberculosis control in the era of HIV , 2005, Nature Reviews Immunology.

[82]  M. Weinstein,et al.  Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d’Ivoire: a trial-based analysis , 2005, AIDS.

[83]  A. Harries,et al.  Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi? , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[84]  A. Sturm,et al.  Effectiveness of cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa , 2005, AIDS.

[85]  A. Harries,et al.  Long-term outcome in patients registered with tuberculosis in Zomba, Malawi: mortality at 7 years according to initial HIV status and type of TB. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[86]  Eric Goemaere,et al.  Integrating tuberculosis and HIV care in the primary care setting in South Africa , 2004, Tropical medicine & international health : TM & IH.

[87]  U. Lalloo,et al.  Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[88]  A. Crampin,et al.  Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi. , 2004, Bulletin of the World Health Organization.

[89]  Ej Lee,et al.  Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana , 2003, The Lancet.

[90]  Brian G. Williams,et al.  Antiretroviral Drugs for Tuberculosis Control in the Era of HIV/AIDS , 2003, Science.

[91]  C. Dye,et al.  Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[92]  A. Harries,et al.  Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi , 2003, AIDS.

[93]  P. Glaziou,et al.  Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia. , 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[94]  R. Wood,et al.  Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study , 2002, The Lancet.

[95]  A. Harries,et al.  Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa , 2001, AIDS.

[96]  R. Rumble,et al.  Improving microscope quality is a good investment for under-resourced laboratories. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[97]  I. Bastian,et al.  A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[98]  J. Porter,et al.  Is cough alone adequate to screen HIV-positive persons for tuberculosis preventive therapy in developing countries? , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[99]  De Cock Km,et al.  Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. , 1999 .

[100]  J. Karon,et al.  Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial , 1999, The Lancet.

[101]  J. T. Crawford,et al.  An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. , 1992, The New England journal of medicine.

[102]  S. Lucas,et al.  Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis , 1991, The Lancet.

[103]  S. Theobald,et al.  International Journal for Equity in Health Open Access Who Has Access to Counseling and Testing and Anti-retroviral Therapy in Malawi – an Equity Analysis , 2009 .

[104]  S. Lawn,et al.  Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[105]  B. Eley,et al.  High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[106]  Richard Horton.  Venice statement: global health initiatives and health systems , 2009 .

[107]  L. Myer,et al.  Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. , 2007, American journal of respiratory and critical care medicine.

[108]  C. Duncombe,et al.  Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children adolescents and adults. Recommendations for a public health approach. , 2006 .

[109]  K. Floyd,et al.  The Stop TB Strategy: building on and enhancing DOTS to meet the TB-related Millennium Development Goals. , 2006 .

[110]  C. Allers,et al.  Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006 revision. , 2006 .

[111]  A. Harries,et al.  Interim policy on collaborative TB / HIV activities. , 2004 .

[112]  N. Hargreaves,et al.  Guidelines for implementing collaborative TB and HIV programme activities. , 2003 .

[113]  D. Maher,et al.  An analysis of interaction between TB and HIV / AIDS programmes in sub-Saharan Africa. , 2001 .

[114]  N. Ford,et al.  Journal of the International Aids Society Open Access Antiretroviral Treatment Outcomes from a Nurse-driven, Community-supported Hiv/aids Treatment Programme in Rural Lesotho: Observational Cohort Assessment at Two Years , 2022 .